{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:04:05Z","timestamp":1790251445099,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":105,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["IC-12044(11)\/10\/2021-ICD-DBT"],"award-info":[{"award-number":["IC-12044(11)\/10\/2021-ICD-DBT"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"DST | Science and Engineering Research Board","doi-asserted-by":"publisher","award":["IPA\/2020\/000007"],"award-info":[{"award-number":["IPA\/2020\/000007"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10096-0","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:44:56Z","timestamp":1781160296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chemical degradation of Human p38-MAPK reveals it as a potential host target to combat parasitic infections by Leishmania donovani and Plasmodium falciparum"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8273-7158","authenticated-orcid":false,"given":"Jhalak","family":"Singhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashima","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanka","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajala Deethamvali","family":"Ghouse Peer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramendra Pati","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3046-3671","authenticated-orcid":false,"given":"Anand","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5286-6605","authenticated-orcid":false,"given":"Shailja","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"10096_CR1","first-page":"309","volume":"26","author":"J van Griensven","year":"2012","unstructured":"van Griensven, J. & Diro, E. Visceral Leishmaniasis. Infect. Dis. Clin. 26, 309\u2013322 (2012).","journal-title":"Infect. Dis. Clin."},{"key":"10096_CR2","doi-asserted-by":"publisher","first-page":"9872095","DOI":"10.1155\/2018\/9872095","volume":"2018","author":"K Bi","year":"2018","unstructured":"Bi, K. et al. Current visceral Leishmaniasis research: a research review to inspire future study. Biomed. Res. Int. 2018, 9872095 (2018).","journal-title":"Biomed. Res. Int."},{"key":"10096_CR3","unstructured":"Leishmaniasis. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis. (2023)."},{"key":"10096_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0065-308X(08)60208-0","volume":"32","author":"FY Liew","year":"1993","unstructured":"Liew, F. Y. & O\u2019Donnell, C. A. Immunology of Leishmaniasis. Adv. Parasitol. 32, 161\u2013259 (1993).","journal-title":"Adv. Parasitol."},{"key":"10096_CR5","doi-asserted-by":"publisher","first-page":"6289","DOI":"10.1128\/IAI.68.11.6289-6293.2000","volume":"68","author":"WH Murray","year":"2000","unstructured":"Murray, W. H., Jungbluth, A., Ritter, E., Montelibano, C. & Marino, M. W. Visceral Leishmaniasis in mice devoid of tumor necrosis factor and response to treatment. Infect. Immun. 68, 6289\u20136293 (2000).","journal-title":"Infect. Immun."},{"key":"10096_CR6","first-page":"1","volume":"43","author":"O Brandonisio","year":"2001","unstructured":"Brandonisio, O. et al. Nitric oxide production by Leishmania-infected macrophages and modulation by cytokines and prostaglandins. Parassitologia 43, 1\u20136 (2001).","journal-title":"Parassitologia"},{"key":"10096_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-016-1472-y","volume":"9","author":"EH Roma","year":"2016","unstructured":"Roma, E. H. et al. Impact of reactive oxygen species (ROS) on the control of parasite loads and inflammation in Leishmania amazonensis infection. Parasites Vectors 9, 1\u201313 (2016).","journal-title":"Parasites Vectors"},{"key":"10096_CR8","doi-asserted-by":"publisher","first-page":"34528","DOI":"10.1074\/jbc.M110.125302","volume":"285","author":"F Mollinedo","year":"2010","unstructured":"Mollinedo, F., Janssen, H., De La Iglesia-Vicente, J., Villa-Pulgarin, J. A. & Calafat, J. Selective fusion of azurophilic granules with Leishmania-containing phagosomes in human neutrophils. J. Biol. Chem. 285, 34528\u201334536 (2010).","journal-title":"J. Biol. Chem."},{"key":"10096_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13071-016-1540-3","volume":"9","author":"JP de Menezes","year":"2016","unstructured":"de Menezes, J. P., Saraiva, E. M. & da Rocha-Azevedo, B. The site of the bite: Leishmania interaction with macrophages, neutrophils and the extracellular matrix in the dermis. Parasit. Vectors 9, 264 (2016).","journal-title":"Parasit. Vectors"},{"key":"10096_CR10","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","volume":"31","author":"ML Murphy","year":"2001","unstructured":"Murphy, M. L., Wille, U., Villegas, E. N., Hunter, C. A. & Farrell, J. P. IL-10 mediates susceptibility to Leishmania donovani infection. Eur. J. Immunol. 31, 2848\u20132856 (2001).","journal-title":"Eur. J. Immunol."},{"key":"10096_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.humimm.2009.01.007","volume":"70","author":"LR Castellano","year":"2009","unstructured":"Castellano, L. R. et al. Th1\/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-\u03b3 production. Hum. Immunol. 70, 383\u2013390 (2009).","journal-title":"Hum. Immunol."},{"key":"10096_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.tice.2012.08.003","volume":"44","author":"LT Cyrino","year":"2012","unstructured":"Cyrino, L. T., Ara\u00fajo, A. P., Joazeiro, P. P., Vicente, C. P. & Giorgio, S. In vivo and in vitro Leishmania amazonensis infection induces autophagy in macrophages. Tissue Cell 44, 401\u2013408 (2012).","journal-title":"Tissue Cell"},{"key":"10096_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s13071-015-0974-3","volume":"8","author":"B Frank","year":"2015","unstructured":"Frank, B. et al. Autophagic digestion of Leishmania major by host macrophages is associated with differential expression of BNIP3, CTSE, and the miRNAs miR-101c, miR-129, and miR-210. Parasites Vectors 8, 404 (2015).","journal-title":"Parasites Vectors"},{"key":"10096_CR14","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1074\/jbc.M117.808675","volume":"293","author":"SA Thomas","year":"2018","unstructured":"Thomas, S. A., Nandan, D., Kass, J. & Reiner, N. E. Countervailing, time-dependent effects on host autophagy promote intracellular survival of Leishmania. J. Biol. Chem. 293, 2617\u20132630 (2018).","journal-title":"J. Biol. Chem."},{"key":"10096_CR15","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.4049\/jimmunol.1801053","volume":"202","author":"DM Pitale","year":"2019","unstructured":"Pitale, D. M., Gendalur, N. S., Descoteaux, A. & Shaha, C. Leishmania donovani Induces autophagy in human blood\u2013derived neutrophils. J. Immunol. 202, 1163\u20131175 (2019).","journal-title":"J. Immunol."},{"key":"10096_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2022.878136","volume":"12","author":"J Singhal","year":"2022","unstructured":"Singhal, J. et al. Host SUMOylation pathway negatively regulates protective immune responses and promotes Leishmania donovani survival. Front. Cell. Infect. Microbiol. 12, 1\u201317 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10096_CR17","unstructured":"Organization, W. H. World Malaria Report 2024. (2024)."},{"key":"10096_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","volume":"19","author":"SL Croft","year":"2006","unstructured":"Croft, S. L., Sundar, S. & Fairlamb, A. H. Drug resistance in leishmaniasis. Clin. Microbiol. Rev. 19, 111\u2013126 (2006).","journal-title":"Clin. Microbiol. Rev."},{"key":"10096_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/0974-777X.62887","volume":"2","author":"J Chakravarty","year":"2010","unstructured":"Chakravarty, J. & Sundar, S. Drug resistance in leishmaniasis. J. Glob. Infect. Dis. 2, 167\u2013176 (2010).","journal-title":"J. Glob. Infect. Dis."},{"key":"10096_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a025619","volume":"7","author":"D Menard","year":"2017","unstructured":"Menard, D. & Dondorp, A. Antimalarial drug resistance: a threat to malaria elimination. Cold Spring Harb. Perspect. Med. 7, 1\u201324 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10096_CR21","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/embor.2010.160","volume":"11","author":"H Gehart","year":"2010","unstructured":"Gehart, H., Kumpf, S., Ittner, A. & Ricci, R. MAPK signalling in cellular metabolism: stress or wellness? EMBO Rep. 11, 834\u2013840 (2010).","journal-title":"EMBO Rep."},{"key":"10096_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/649079","volume":"2012","author":"SAL Corr\u00eaa","year":"2012","unstructured":"Corr\u00eaa, S. A. L. & Eales, K. L. The role of p38 MAPK and Its Substrates in Neuronal Plasticity and Neurodegenerative Disease. J. Signal Transduct. 2012, 1\u201312 (2012).","journal-title":"J. Signal Transduct."},{"key":"10096_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1751-2980.2011.00525.x","volume":"12","author":"YJ Feng","year":"2011","unstructured":"Feng, Y. J. & Li, Y. Y. The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease. J. Dig. Dis. 12, 327\u2013332 (2011).","journal-title":"J. Dig. Dis."},{"key":"10096_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.biocel.2017.11.003","volume":"94","author":"JD O\u2019Neil","year":"2018","unstructured":"O\u2019Neil, J. D., Ammit, A. J. & Clark, A. R. MAPK p38 regulates inflammatory gene expression via tristetraprolin: doing good by stealth. Int. J. Biochem. Cell Biol. 94, 6\u20139 (2018).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10096_CR25","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1517\/13543784.17.10.1411","volume":"17","author":"P Chopra","year":"2008","unstructured":"Chopra, P., Kanoje, V., Semwal, A. & Ray, A. Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases. Expert Opin. Investig. Drugs 17, 1411\u20131425 (2008).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10096_CR26","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1021\/jm9012906","volume":"53","author":"DM Goldstein","year":"2010","unstructured":"Goldstein, D. M., Kuglstatter, A., Lou, Y. & Soth, M. J. Selective p38\u03b1 inhibitors clinically evaluated for the treatment of chronic inflammatory disorders. J. Med. Chem. 53, 2345\u20132353 (2010).","journal-title":"J. Med. Chem."},{"key":"10096_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/BJ20100323","volume":"429","author":"A Cuadrado","year":"2010","unstructured":"Cuadrado, A. & Nebreda, A. R. Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429, 403\u2013417 (2010).","journal-title":"Biochem. J."},{"key":"10096_CR28","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2174\/1568026054985902","volume":"5","author":"GL Schieven","year":"2005","unstructured":"Schieven, G. L. The biology of p38 kinase: a central role in inflammation. Curr. Top. Med. Chem. 5, 921\u2013928 (2005).","journal-title":"Curr. Top. Med. Chem."},{"key":"10096_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.exppara.2015.12.005","volume":"163","author":"J Rodr\u00edguez-Gonz\u00e1lez","year":"2016","unstructured":"Rodr\u00edguez-Gonz\u00e1lez, J., Wilkins-Rodr\u00edguez, A., Argueta-Donohu\u00e9, J., Aguirre-Garc\u00eda, M. & Guti\u00e9rrez-Kobeh, L. Leishmania mexicana promastigotes down regulate JNK and p-38 MAPK activation: role in the inhibition of camptothecin-induced apoptosis of monocyte-derived dendritic cells. Exp. Parasitol. 163, 57\u201367 (2016).","journal-title":"Exp. Parasitol."},{"key":"10096_CR30","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1128\/IAI.70.9.5026-5035.2002","volume":"70","author":"M Junghae","year":"2002","unstructured":"Junghae, M. & Raynes, J. G. Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages. Infect. Immun. 70, 5026\u20135035 (2002).","journal-title":"Infect. Immun."},{"key":"10096_CR31","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.4049\/jimmunol.178.2.1077","volume":"178","author":"Z Yang","year":"2007","unstructured":"Yang, Z., Mosser, D. M. & Zhang, X. Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J. Immunol. 178, 1077\u20131085 (2007).","journal-title":"J. Immunol."},{"key":"10096_CR32","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1016\/j.molimm.2008.02.019","volume":"45","author":"R Ben-Othman","year":"2008","unstructured":"Ben-Othman, R., Guizani-Tabbane, L. & Dellagi, K. Leishmania initially activates but subsequently down-regulates intracellular mitogen-activated protein kinases and nuclear factor-kappaB signaling in macrophages. Mol. Immunol. 45, 3222\u20133229 (2008).","journal-title":"Mol. Immunol."},{"key":"10096_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep22335","volume":"6","author":"S Banerjee","year":"2016","unstructured":"Banerjee, S. et al. Attenuated Leishmania induce pro-inflammatory mediators and influence leishmanicidal activity by p38 MAPK dependent phagosome maturation in Leishmania donovani co-infected macrophages. Sci. Rep. 6, 22335 (2016).","journal-title":"Sci. Rep."},{"key":"10096_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-17829-7","volume":"11","author":"JD Adderley","year":"2020","unstructured":"Adderley, J. D. et al. Analysis of erythrocyte signalling pathways during Plasmodium falciparum infection identifies targets for host-directed antimalarial intervention. Nat. Commun. 11, 1\u201313 (2020).","journal-title":"Nat. Commun."},{"key":"10096_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-8-105","volume":"8","author":"Y Wu","year":"2009","unstructured":"Wu, Y. et al. Identification of phosphorylated proteins in erythrocytes infected by the human malaria parasite Plasmodium falciparum. Malar. J. 8, 105 (2009).","journal-title":"Malar. J."},{"key":"10096_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3389\/fimmu.2017.00349","volume":"8","author":"R Soni","year":"2017","unstructured":"Soni, R., Sharma, D., Rai, P., Sharma, B. & Bhatt, T. K. Signaling strategies of malaria parasite for its survival, proliferation, and infection during erythrocytic stage. Front. Immunol. 8, 349 (2017).","journal-title":"Front. Immunol."},{"key":"10096_CR37","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1146\/annurev-biochem-060614-034157","volume":"84","author":"NJ Spillman","year":"2015","unstructured":"Spillman, N. J., Beck, J. R. & Goldberg, D. E. Protein export into malaria parasite-infected erythrocytes: mechanisms and functional consequences. Annu. Rev. Biochem. 84, 813\u2013841 (2015).","journal-title":"Annu. Rev. Biochem."},{"key":"10096_CR38","doi-asserted-by":"publisher","first-page":"e23217","DOI":"10.7554\/eLife.23217","volume":"6","author":"NA Counihan","year":"2017","unstructured":"Counihan, N. A. et al. Plasmodium falciparum parasites deploy RhopH2 into the host erythrocyte to obtain nutrients, grow and replicate. Elife 6, e23217 (2017).","journal-title":"Elife"},{"key":"10096_CR39","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nm0398-358","volume":"4","author":"PC Bull","year":"1998","unstructured":"Bull, P. C. et al. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat. Med. 4, 358\u2013360 (1998).","journal-title":"Nat. Med."},{"key":"10096_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/MMBR.00013-19","volume":"83","author":"JD Warncke","year":"2019","unstructured":"Warncke, J. D. & Beck, H.-P. Host cytoskeleton remodeling throughout the blood stages of Plasmodium falciparum. Microbiol. Mol. Biol. Rev. 83, 10\u20131128 (2019).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10096_CR41","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1159\/000335859","volume":"28","author":"S Gatidis","year":"2011","unstructured":"Gatidis, S. et al. P38 MAPK activation and function following osmotic shock of erythrocytes. Cell. Physiol. Biochem. 28, 1279\u20131286 (2011).","journal-title":"Cell. Physiol. Biochem."},{"key":"10096_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.cr.7290257","volume":"15","author":"T Zarubin","year":"2005","unstructured":"Zarubin, T. & Han, J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15, 11\u201318 (2005).","journal-title":"Cell Res."},{"key":"10096_CR43","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.exppara.2011.02.016","volume":"128","author":"MJ Brumlik","year":"2011","unstructured":"Brumlik, M. J. et al. Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication. Exp. Parasitol. 128, 170\u2013175 (2011).","journal-title":"Exp. Parasitol."},{"key":"10096_CR44","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S1473-3099(16)00078-5","volume":"16","author":"A Zumla","year":"2016","unstructured":"Zumla, A. et al. Host-directed therapies for infectious diseases: current status, recent progress, and future prospects. Lancet Infect. Dis. 16, e47\u2013e63 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"10096_CR45","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/13543776.2020.1749263","volume":"30","author":"V Haller","year":"2020","unstructured":"Haller, V., Nahidino, P., Forster, M. & Laufer, S. A. An updated patent review of p38 MAP kinase inhibitors (2014-2019). Expert Opin. Ther. Pat. 30, 453\u2013466 (2020).","journal-title":"Expert Opin. Ther. Pat."},{"key":"10096_CR46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181\u2013200 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"10096_CR47","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s43556-022-00112-0","volume":"3","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. An overview of PROTACs: a promising drug discovery paradigm. Mol. Biomed. 3, 46 (2022).","journal-title":"Mol. Biomed."},{"key":"10096_CR48","doi-asserted-by":"publisher","first-page":"867","DOI":"10.4155\/fmc-2023-0072","volume":"15","author":"MP Kannan","year":"2023","unstructured":"Kannan, M. P. et al. Advancement of targeted protein degradation strategies as therapeutics for undruggable disease targets. Future Med. Chem. 15, 867\u2013883 (2023).","journal-title":"Future Med. Chem."},{"key":"10096_CR49","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.apsb.2020.11.001","volume":"11","author":"G Luo","year":"2021","unstructured":"Luo, G. et al. Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo. Acta Pharm. Sin. B 11, 1300\u20131314 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"10096_CR50","doi-asserted-by":"publisher","first-page":"10328","DOI":"10.3390\/ijms231810328","volume":"23","author":"T Yao","year":"2022","unstructured":"Yao, T., Xiao, H., Wang, H. & Xu, X. Recent advances in PROTACs for drug targeted protein research. Int. J. Mol. Sci. 23, 10328 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"10096_CR51","doi-asserted-by":"publisher","first-page":"110449","DOI":"10.1016\/j.jbc.2025.110449","volume":"301","author":"L Shen","year":"2025","unstructured":"Shen, L. et al. Targeted degradation of \u03b1-synuclein by arginine-based PROTACs. J. Biol. Chem. 301, 110449 (2025).","journal-title":"J. Biol. Chem."},{"key":"10096_CR52","doi-asserted-by":"publisher","first-page":"fuaf046","DOI":"10.1093\/femsre\/fuaf046","volume":"49","author":"A Bazzacco","year":"2025","unstructured":"Bazzacco, A., Mercorelli, B. & Loregian, A. PROteolysis TArgeting Chimeras (PROTACs) and beyond: targeted degradation as a new path to fight microbial pathogens. FEMS Microbiol. Rev. 49, fuaf046 (2025).","journal-title":"FEMS Microbiol. Rev."},{"key":"10096_CR53","doi-asserted-by":"publisher","first-page":"12858","DOI":"10.3390\/ijms222312858","volume":"22","author":"F Hahn","year":"2021","unstructured":"Hahn, F. et al. Development of a PROTAC-based targeting strategy provides a mechanistically unique mode of anti-cytomegalovirus activity. Int. J. Mol. Sci. 22, 12858 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"10096_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11429-w","volume":"10","author":"M de Wispelaere","year":"2019","unstructured":"de Wispelaere, M. et al. Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations. Nat. Commun. 10, 3468 (2019).","journal-title":"Nat. Commun."},{"key":"10096_CR55","doi-asserted-by":"publisher","first-page":"112451","DOI":"10.1016\/j.ejmech.2020.112451","volume":"201","author":"C Donoghue","year":"2020","unstructured":"Donoghue, C. et al. Optimal linker length for small molecule PROTACs that selectively target p38\u03b1 and p38\u03b2 for degradation. Eur. J. Med. Chem. 201, 112451 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"10096_CR56","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1038\/leu.2012.119","volume":"26","author":"A Lopez-Girona","year":"2012","unstructured":"Lopez-Girona, A. et al. Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia 26, 2326\u20132335 (2012).","journal-title":"Leukemia"},{"key":"10096_CR57","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1016\/j.bmcl.2011.04.121","volume":"21","author":"SR Selness","year":"2011","unstructured":"Selness, S. R. et al. Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase. Bioorg. Med. Chem. Lett. 21, 4066\u20134071 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10096_CR58","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.virol.2017.05.012","volume":"508","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z. et al. PD169316, a specific p38 inhibitor, shows antiviral activity against Enterovirus71. Virology 508, 150\u2013158 (2017).","journal-title":"Virology"},{"key":"10096_CR59","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0014-4886(03)00268-1","volume":"183","author":"GVW Johnson","year":"2003","unstructured":"Johnson, G. V. W. & Bailey, C. D. C. The p38 MAP kinase signaling pathway in Alzheimer\u2019s disease. Exp. Neurol. 183, 263\u2013268 (2003).","journal-title":"Exp. Neurol."},{"key":"10096_CR60","first-page":"199","volume":"1","author":"AD Bachstetter","year":"2010","unstructured":"Bachstetter, A. D. & Van Eldik, L. J. The p38 MAP kinase family as regulators of proinflammatory cytokine production in degenerative diseases of the CNS. Aging Dis. 1, 199\u2013211 (2010).","journal-title":"Aging Dis."},{"key":"10096_CR61","doi-asserted-by":"publisher","first-page":"106661","DOI":"10.1016\/j.actatropica.2022.106661","volume":"235","author":"S Kumari","year":"2022","unstructured":"Kumari, S. et al. Amphotericin B: a drug of choice for visceral Leishmaniasis. Acta Trop. 235, 106661 (2022).","journal-title":"Acta Trop."},{"key":"10096_CR62","doi-asserted-by":"publisher","first-page":"e149915","DOI":"10.1172\/jci.insight.149915","volume":"6","author":"CM Brennan","year":"2021","unstructured":"Brennan, C. M., Emerson, C. P. J., Owens, J. & Christoforou, N. p38 MAPKs\u2014roles in skeletal muscle physiology, disease mechanisms, and as potential therapeutic targets. JCI Insight 6, e149915 (2021).","journal-title":"JCI Insight"},{"key":"10096_CR63","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nri1865","volume":"6","author":"JD Ashwell","year":"2006","unstructured":"Ashwell, J. D. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat. Rev. Immunol. 6, 532\u2013540 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"10096_CR64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.canlet.2016.10.008","volume":"384","author":"X Zou","year":"2017","unstructured":"Zou, X. & Blank, M. Targeting p38 MAP kinase signaling in cancer through post-translational modifications. Cancer Lett. 384, 19\u201326 (2017).","journal-title":"Cancer Lett."},{"key":"10096_CR65","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.3390\/ijms21072346","volume":"21","author":"J Yue","year":"2020","unstructured":"Yue, J. & L\u00f3pez, J. M. Understanding MAPK signaling pathways in apoptosis. Int. J. Mol. Sci. 21, 2346 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"10096_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19582-3","volume":"11","author":"K Kirsch","year":"2020","unstructured":"Kirsch, K. et al. Co-regulation of the transcription controlling ATF2 phosphoswitch by JNK and p38. Nat. Commun. 11, 5769 (2020).","journal-title":"Nat. Commun."},{"key":"10096_CR67","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo, Q. et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct. Target. Ther. 9, 53 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"10096_CR68","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3390\/ijms21061913","volume":"21","author":"A Mart\u00ednez-Lim\u00f3n","year":"2020","unstructured":"Mart\u00ednez-Lim\u00f3n, A., Joaquin, M., Caballero, M., Posas, F. & de Nadal, E. The p38 pathway: from biology to cancer therapy. Int. J. Mol. Sci. 21, 1913 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"10096_CR69","doi-asserted-by":"publisher","first-page":"115973","DOI":"10.1016\/j.bcp.2023.115973","volume":"220","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Function and inhibition of P38 MAP kinase signaling: targeting multiple inflammation diseases. Biochem. Pharmacol. 220, 115973 (2024).","journal-title":"Biochem. Pharmacol."},{"key":"10096_CR70","doi-asserted-by":"publisher","first-page":"569751","DOI":"10.1155\/2013\/569751","volume":"2013","author":"A Mavropoulos","year":"2013","unstructured":"Mavropoulos, A., Rigopoulou, E. I., Liaskos, C., Bogdanos, D. P. & Sakkas, L. I. The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis. Clin. Dev. Immunol. 2013, 569751 (2013).","journal-title":"Clin. Dev. Immunol."},{"key":"10096_CR71","first-page":"1","volume":"2","author":"AO Fadaka","year":"2017","unstructured":"Fadaka, A. O., Ojo, O. A., Osukoya, O. A., Akuboh, O. & Ajiboye, B. O. Role of p38 MAPK signaling in neurodegenerative diseases: a mechanistic perspective. Ann. Neurodegener. Disord. 2, 1\u201310 (2017).","journal-title":"Ann. Neurodegener. Disord."},{"key":"10096_CR72","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1515\/revneuro-2018-0008","volume":"30","author":"G Kheiri","year":"2018","unstructured":"Kheiri, G., Dolatshahi, M., Rahmani, F. & Rezaei, N. Role of p38\/MAPKs in Alzheimer\u2019s disease: implications for amyloid beta toxicity targeted therapy. Rev. Neurosci. 30, 9\u201330 (2018).","journal-title":"Rev. Neurosci."},{"key":"10096_CR73","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1189\/jlb.0909644","volume":"88","author":"S Kar","year":"2010","unstructured":"Kar, S., Ukil, A., Sharma, G. & Das, P. K. MAPK-directed phosphatases preferentially regulate pro- and anti-inflammatory cytokines in experimental visceral leishmaniasis: involvement of distinct protein kinase C isoforms. J. Leukoc. Biol. 88, 9\u201320 (2010).","journal-title":"J. Leukoc. Biol."},{"key":"10096_CR74","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1128\/AAC.03997-14","volume":"59","author":"P Gupta","year":"2015","unstructured":"Gupta, P., Das, P. K. & Ukil, A. Antileishmanial effect of 18\u03b2-glycyrrhetinic acid is mediated by Toll-like receptor-dependent canonical and noncanonical p38 activation. Antimicrob. Agents Chemother. 59, 2531\u20132539 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"10096_CR75","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/B978-0-12-407679-2.00005-3","volume":"82","author":"G Gupta","year":"2013","unstructured":"Gupta, G., Oghumu, S. & Satoskar, A. R. Mechanisms of immune evasion in leishmaniasis. Adv. Appl. Microbiol. 82, 155\u2013184 (2013).","journal-title":"Adv. Appl. Microbiol."},{"key":"10096_CR76","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/iub.1759","volume":"70","author":"A Saha","year":"2018","unstructured":"Saha, A., Basu, M. & Ukil, A. Recent advances in understanding Leishmania donovani infection: the importance of diverse host regulatory pathways. IUBMB Life 70, 593\u2013601 (2018).","journal-title":"IUBMB Life"},{"key":"10096_CR77","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/cdd.2016.101","volume":"23","author":"P Gupta","year":"2016","unstructured":"Gupta, P., Srivastav, S., Saha, S., Das, P. K. & Ukil, A. Leishmania donovani inhibits macrophage apoptosis and pro-inflammatory response through AKT-mediated regulation of \u03b2-catenin and FOXO-1. Cell Death Differ. 23, 1815\u20131826 (2016).","journal-title":"Cell Death Differ."},{"key":"10096_CR78","doi-asserted-by":"publisher","first-page":"107366","DOI":"10.1016\/j.jbc.2024.107366","volume":"300","author":"S Roy","year":"2024","unstructured":"Roy, S., Roy, S., Halder, S., Jana, K. & Ukil, A. Leishmania exploits host cAMP\/EPAC\/calcineurin signaling to induce an IL-33\u2013mediated anti-inflammatory environment for the establishment of infection. J. Biol. Chem. 300, 107366 (2024).","journal-title":"J. Biol. Chem."},{"key":"10096_CR79","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1189\/jlb.68.6.897","volume":"68","author":"Z Xing","year":"2000","unstructured":"Xing, Z., Zganiacz, A. & Santosuosso, M. Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-alpha and nitric oxide from macrophages via IFN-gamma induction. J. Leukoc. Biol. 68, 897\u2013902 (2000).","journal-title":"J. Leukoc. Biol."},{"key":"10096_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005413","volume":"11","author":"JC Dos Santos","year":"2017","unstructured":"Dos Santos, J. C. et al. Cytokines and microbicidal molecules regulated by IL-32 in THP-1-derived human macrophages infected with New World Leishmania species. PLoS Negl. Trop. Dis. 11, e0005413 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10096_CR81","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1365-2249.2008.03741.x","volume":"154","author":"D Chandra","year":"2008","unstructured":"Chandra, D. & Naik, S. Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage\/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism. Clin. Exp. Immunol. 154, 224\u2013234 (2008).","journal-title":"Clin. Exp. Immunol."},{"key":"10096_CR82","doi-asserted-by":"publisher","first-page":"116307","DOI":"10.1016\/j.bcp.2024.116307","volume":"225","author":"NH Sarg","year":"2024","unstructured":"Sarg, N. H. et al. The interplay of p38 MAPK signaling and mitochondrial metabolism, a dynamic target in cancer and pathological contexts. Biochem. Pharmacol. 225, 116307 (2024).","journal-title":"Biochem. Pharmacol."},{"key":"10096_CR83","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pt.2014.01.003","volume":"30","author":"SA Desai","year":"2014","unstructured":"Desai, S. A. Why do malaria parasites increase host erythrocyte permeability? Trends Parasitol. 30, 151\u2013159 (2014).","journal-title":"Trends Parasitol."},{"key":"10096_CR84","doi-asserted-by":"publisher","first-page":"16346","DOI":"10.3390\/ijms131216346","volume":"13","author":"S Perc\u00e1rio","year":"2012","unstructured":"Perc\u00e1rio, S. et al. Oxidative stress in malaria. Int. J. Mol. Sci. 13, 16346\u201316372 (2012).","journal-title":"Int. J. Mol. Sci."},{"key":"10096_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellsig.2022.110450","volume":"99","author":"K Hazegh","year":"2022","unstructured":"Hazegh, K. et al. Erythrocyte mitogen-activated protein kinases mediate hemolytic events under osmotic and oxidative stress and in hemolytic diseases. Cell. Signal. 99, 1\u201323 (2022).","journal-title":"Cell. Signal."},{"key":"10096_CR86","doi-asserted-by":"publisher","first-page":"5164","DOI":"10.1073\/pnas.0834959100","volume":"100","author":"VK Goel","year":"2003","unstructured":"Goel, V. K. et al. Band 3 is a host receptor binding merozoite surface protein 1 during the Plasmodium falciparum invasion of erythrocytes. Proc. Natl. Acad. Sci. USA 100, 5164\u20135169 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10096_CR87","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1182\/blood-2005-07-2806","volume":"106","author":"S Perrotta","year":"2005","unstructured":"Perrotta, S. et al. The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: Implications for band 3 function. Blood 106, 4359\u20134365 (2005).","journal-title":"Blood"},{"key":"10096_CR88","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s42003-025-07968-2","volume":"8","author":"G Kumari","year":"2025","unstructured":"Kumari, G. et al. CRISPR\/Cas9-engineering of Kell null erythrocytes to unveil host targeted irresistible antimalarial. Commun. Biol. 8, 730 (2025).","journal-title":"Commun. Biol."},{"key":"10096_CR89","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/IM9.0000000000000127","volume":"5","author":"X Cao","year":"2023","unstructured":"Cao, X. et al. TAK1 deficiency in macrophages increases host susceptibility to Leishmania infection. Infect. Microbes Dis. 5, 127\u2013136 (2023).","journal-title":"Infect. Microbes Dis."},{"key":"10096_CR90","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00764-20","volume":"89","author":"S Saha","year":"2021","unstructured":"Saha, S., Roy, S., Dutta, A., Jana, K. & Ukil, A. Leishmania donovani targets host transcription factor NRF2 to activate antioxidant enzyme HO-1 and transcriptional repressor ATF3 for establishing infection. Infect. Immun. 89, e0076420 (2021).","journal-title":"Infect. Immun."},{"key":"10096_CR91","doi-asserted-by":"publisher","first-page":"114720","DOI":"10.1016\/j.celrep.2024.114720","volume":"43","author":"C Blot","year":"2024","unstructured":"Blot, C. et al. Leishmania infantum exploits the anti-ferroptosis effects of Nrf2 to escape cell death in macrophages. Cell Rep. 43, 114720 (2024).","journal-title":"Cell Rep."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10096-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10096-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10096-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:03:07Z","timestamp":1790247787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10096-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10096"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10096-0","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1247"}}